Statistical Expert for Health Technology Assessment - Homebased work option
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Søborg
Can you see yourself as part of an entrepreneurial team of statisticians, working to apply statistical expertise to ensure fast access to innovative treatments to patients across the world? Do you have a strategic mindset and an appetite for driving change across a large organization? Then you may be our new statistical expert for Health Technology Assessment (HTA). Apply now! The position
You will join the Biostatistics HTA Department within the global Biostatistics organization. Together with other 7 highly motivated specialists, you will help ensure that statistical expertise is leveraged to address the increasing evidence requirements for market and patient access to our innovations. Our department operates across the full Novo Nordisk portfolio of treatments and interfaces with many different parts of the organization, including affiliates and external collaborators. This means that your strategic mindset and ability to build successful long-term partnerships with diverse stakeholders will be crucial in this position. Your primary focus will be the area of Other Serious Chronic Disease, such as cardiovascular disease (CVD), nonalcoholic steatohepatitis (NASH) and chronic kidney disease (CKD). This is an area of great strategic importance to Novo Nordisk. We aspire to integrate HTA statistical considerations early in development, and you will play a crucial role in achieving this goal. By doing so, you will help ensure that we have the necessary evidence at the right time to ensure market and patient access. In your daily work, you will collaborate with health economists, market access specialists, clinical experts, and other statisticians, providing expert statistical input to address HTA and payer evidence needs in different markets. You will oversee the implementation of advanced statistical methods for e.g. indirect treatment comparisons and act as a mentor for less experienced statisticians. You will also be collaborating with external vendors on the handling of network meta-analyses and cost-effectiveness analyses. Qualifications
As a minimum, you meet the following requirements: MSc in Statistics (or similar quantitative background).
5 years of experience within clinical or biostatistical research
Experience with HTA and market access
Experience with R
Fluent in written and spoken English.
It will be a strong advantage if you have a PhD in Statistics (or other relevant area). We are looking for someone with strong interpersonal and communication skills who can act as a driver and leading member of the cross-functional teams that you will be part of. You thrive in a fast-changing environment where there may be few best practices to fall back on, and where experimentation and breaking new land will be a key part of your daily work. Finally, you are able to combine your quality mindset and statistical expertise with pragmatism and a business value mindset. For the right candidate, we offer the opportunity to work mostly homebased from European locations. About the department
In Novo Nordisk Biostatistics, we have an ambition to be strategic partners that impact decision making in product development and clinical practice through data, statistical, and scientific expertise. Biostatistics HTA is a recently established department that operates across the full Novo Nordisk portfolio, spearheading both strategic and tactical support to HTA and Market Access across the product lifecycle. Our department is a hybrid team, with a mix of in-office and home-based specialists who bring together a diversity of scientific backgrounds across statistics, economics, and natural sciences. Working at Novo Nordisk
At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing, and sales – we’re all working to improve the lives of patients. Contact
For more information, please reach out to Anders Gorst-Rasmussen, Director Biostatistics HTA at [email protected] or +4530756803. Deadline
17 December 2023. Note that the interview process will start on the first week of January 2024. You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
You will join the Biostatistics HTA Department within the global Biostatistics organization. Together with other 7 highly motivated specialists, you will help ensure that statistical expertise is leveraged to address the increasing evidence requirements for market and patient access to our innovations. Our department operates across the full Novo Nordisk portfolio of treatments and interfaces with many different parts of the organization, including affiliates and external collaborators. This means that your strategic mindset and ability to build successful long-term partnerships with diverse stakeholders will be crucial in this position. Your primary focus will be the area of Other Serious Chronic Disease, such as cardiovascular disease (CVD), nonalcoholic steatohepatitis (NASH) and chronic kidney disease (CKD). This is an area of great strategic importance to Novo Nordisk. We aspire to integrate HTA statistical considerations early in development, and you will play a crucial role in achieving this goal. By doing so, you will help ensure that we have the necessary evidence at the right time to ensure market and patient access. In your daily work, you will collaborate with health economists, market access specialists, clinical experts, and other statisticians, providing expert statistical input to address HTA and payer evidence needs in different markets. You will oversee the implementation of advanced statistical methods for e.g. indirect treatment comparisons and act as a mentor for less experienced statisticians. You will also be collaborating with external vendors on the handling of network meta-analyses and cost-effectiveness analyses. Qualifications
As a minimum, you meet the following requirements:
In Novo Nordisk Biostatistics, we have an ambition to be strategic partners that impact decision making in product development and clinical practice through data, statistical, and scientific expertise. Biostatistics HTA is a recently established department that operates across the full Novo Nordisk portfolio, spearheading both strategic and tactical support to HTA and Market Access across the product lifecycle. Our department is a hybrid team, with a mix of in-office and home-based specialists who bring together a diversity of scientific backgrounds across statistics, economics, and natural sciences. Working at Novo Nordisk
At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing, and sales – we’re all working to improve the lives of patients. Contact
For more information, please reach out to Anders Gorst-Rasmussen, Director Biostatistics HTA at [email protected] or +4530756803. Deadline
17 December 2023. Note that the interview process will start on the first week of January 2024. You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Forretningsudvikler", og befinder sig i kategorien "Kommunikation, marketing, salg".
Arbejdsstedet er beliggende i Søborg.
Jobbet er oprettet på vores service den 3.11.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Forretningsudvikler
- Søborg
Lignende jobs
-
Strategic Trial Planning Manager - Clinical Develo...
Are you ready to drive the successful strategic planning and management of early phase clinical trials, i.e. ClinPharm/Phase 1 studies? Does oversight and cross functional collaboration motivate yo..Få mere info- Forretningsudvikler
- Søborg
-
Senior Scientist in Late-stage Downstream Developm...
Are you ready to shape the future of API process characterization in late-stage downstream development? Do you have the expertise to drive innovative solutions and ensure seamless tech transfer in .Få mere info- Forretningsudvikler
- Bagsværd
-
Global Trial Manager
Are you passionate about clinical development? Is ensuring that clinical trials produce high-quality data and scientific documentation your top priority? If so, we want you to join our team in Card..Få mere info- Forretningsudvikler
- Søborg
-
Udviklingskonsulent til det sociale børne- og unge...
Få mere info- Forretningsudvikler
- Taastrup
Statistik over udbudte jobs som forretningsudviklere i Søborg
Herunder ser du udviklingen i udbudte forretningsudvikler i Søborg over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forretningsudviklere.
Se flere statistikker her:
Statistik over udbudte forretningsudviklere i Søborg over tid
| Dato | Alle jobs som forretningsudviklere |
|---|---|
| 22. november 2024 | 17 |
| 21. november 2024 | 17 |
| 20. november 2024 | 15 |
| 19. november 2024 | 12 |
| 18. november 2024 | 10 |
| 17. november 2024 | 10 |
| 16. november 2024 | 10 |
| 15. november 2024 | 10 |
| 14. november 2024 | 10 |
| 13. november 2024 | 9 |
| 12. november 2024 | 8 |
| 11. november 2024 | 8 |
| 10. november 2024 | 7 |
| 9. november 2024 | 7 |
| 8. november 2024 | 6 |
| 7. november 2024 | 6 |
| 6. november 2024 | 6 |
| 5. november 2024 | 6 |
| 4. november 2024 | 7 |
| 3. november 2024 | 6 |
| 2. november 2024 | 6 |
| 1. november 2024 | 6 |
| 31. oktober 2024 | 8 |
| 30. oktober 2024 | 7 |
| 29. oktober 2024 | 6 |
| 28. oktober 2024 | 6 |
| 27. oktober 2024 | 7 |
| 26. oktober 2024 | 7 |
| 25. oktober 2024 | 8 |
| 24. oktober 2024 | 8 |
| 23. oktober 2024 | 8 |